Hong-yue M. Lai
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Gut microbiome signatures discriminate deep vein thrombosis through machine learning and metabolic analysis.
Journal: Scientific reports
Published: January 30, 2026
KLK10 Upregulation Drives Aggressiveness and Radioresistance and Has a Negative Prognostic Impact on Rectal Cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: October 21, 2025
Elevated MS4A12 expression is indicative of resistance to concurrent chemoradiotherapy and inferior survival in patients with rectal cancer.
Journal: Radiation oncology (London, England)
Published: May 18, 2025
High Intelectin-1 Expression Associated with Aggressive Tumor Behavior and Worse Survival in Rectal Cancer.
Journal: OncoTargets and therapy
Published: July 25, 2024
Low CXCL11 expression is indicative of poor prognosis in rectal cancer patients undergoing preoperative chemoradiotherapy: a retrospective cohort study.
Journal: Virchows Archiv : an international journal of pathology
Published: July 09, 2024
The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma.
Journal: Asian journal of surgery
Published: May 01, 2024
SYNPO2 upregulation is an unfavorable prognostic factor for nasopharyngeal carcinoma patients.
Journal: Medicine
Published: July 28, 2023
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma.
Journal: Oncology letters
Published: April 28, 2023
Enhancement of capsular hypermucoviscosity in Klebsiella pneumoniae by Acanthamoeba.
Journal: PLoS neglected tropical diseases
Published: April 20, 2023
REG3A overexpression functions as a negative predictive and prognostic biomarker in rectal cancer patients receiving CCRT.
Journal: Histology and histopathology
Published: April 12, 2023
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma.
Journal: Scientific reports
Published: February 10, 2023
Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma.
Journal: Frontiers in bioscience (Landmark edition)
Published: December 24, 2022
Last Updated: 09/26/2026